发明公开
EP2496942A1 METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE 有权
方法和组合物诊断和预后肾损伤和肾功能衰竭的

  • 专利标题: METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
  • 专利标题(中): 方法和组合物诊断和预后肾损伤和肾功能衰竭的
  • 申请号: EP10829198.0
    申请日: 2010-11-05
  • 公开(公告)号: EP2496942A1
    公开(公告)日: 2012-09-12
  • 发明人: ANDERBERG, JosephGRAY, JeffMCPHERSON, PaulNAKAMURA, KevinKAMPF, James, Patrick
  • 申请人: Astute Medical, Inc.
  • 申请人地址: Blg 2 R. 645 3550 General Atomics Court San Diego, CA 92121 US
  • 专利权人: Astute Medical, Inc.
  • 当前专利权人: Astute Medical, Inc.
  • 当前专利权人地址: Blg 2 R. 645 3550 General Atomics Court San Diego, CA 92121 US
  • 代理机构: Schiweck, Weinzierl & Koch
  • 优先权: US259540P 20091109; US259142P 20091107; US259140P 20091107; US259141P 20091107; US259511P 20091109; US259163P 20091107; US259143P 20091107
  • 国际公布: WO2011057147 20110512
  • 主分类号: G01N33/53
  • IPC分类号: G01N33/53
METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
摘要:
The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of Cathepsin B, Renin, Dipeptidyl Peptidase IV, Neprilysin, Beta-2-microglobulin, Carbonic anhydrase IX, and C-X-C motif chemokine 2 as diagnostic and prognostic biomarkers in renal injuries.
信息查询
0/0